Eric Bjerkholt
2023
In 2023, Eric Bjerkholt earned a total compensation of $4.3M as Chief Financial Officer at Mirum Pharmaceuticals.
Compensation breakdown
| Non-Equity Incentive Plan | $95,246 |
|---|---|
| Option Awards | $2,417,470 |
| Salary | $151,562 |
| Stock Awards | $1,673,650 |
| Total | $4,337,928 |
Bjerkholt received $2.4M in option awards, accounting for 56% of the total pay in 2023.
Bjerkholt also received $95.2K in non-equity incentive plan, $151.6K in salary and $1.7M in stock awards.
Rankings
In 2023, Eric Bjerkholt's compensation ranked 162nd out of 2,647 executives tracked by ExecPay. In other words, Bjerkholt earned more than 93.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 162 out of 2,647 | 94th |
Division Manufacturing | 83 out of 1,447 | 94th |
Major group Chemicals And Allied Products | 52 out of 817 | 94th |
Industry group Drugs | 51 out of 783 | 94th |
Industry Pharmaceutical Preparations | 34 out of 555 | 94th |
Source: SEC filing on April 23, 2024.
Bjerkholt's colleagues
We found two more compensation records of executives who worked with Eric Bjerkholt at Mirum Pharmaceuticals in 2023.